ASX Announcements

Consolidation/Split - NEU
Notification under Listing Rule 7.20 of share reorganisation
Appendix 4C - quarterly
Neuren FDA meeting confirms Phase 3 plan for Rett syndrome
Investor presentation, 6 October 2017
Presentations and publication for Rett syndrome trials
Change of Director's Interest Notice
Change of Director's Interest Notice
Change of Director's Interest Notice
Notice under section 708A(5)(e) of the Corporations Act